| For: | Li CJ, Wang YK, Zhang SM, Ren MD, He SX. Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast. World J Gastroenterol 2023; 29(42): 5751-5767 [PMID: 38075848 DOI: 10.3748/wjg.v29.i42.5751] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i42/5751.htm |
| Number | Citing Articles |
| 1 |
Dingwei Liu, Qingting Lu, Jiasheng Fang, Yong Xie, Xiaojiang Zhou. Association between temperature and global incidence of inflammatory bowel disease. Journal of Health, Population and Nutrition 2026; 45(1) doi: 10.1186/s41043-025-01216-3
|
| 2 |
Ziqing Yu, Gechong Ruan, Xiaoyin Bai, Yinghao Sun, Hong Yang, Jiaming Qian. Growing burden of inflammatory bowel disease in China: Findings from the Global Burden of Disease Study 2021 and predictions to 2035. Chinese Medical Journal 2024; 137(23) doi: 10.1097/CM9.0000000000003345
|
| 3 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|
| 4 |
Yihao Ge, Shanshan Zhang, Zekun Li, Hongmin Guo, Xiaohan Li, Zhiyong Li, Fang Dong, Feng Zhang. Global, regional and national level burden of bulimia nervosa from 1990 to 2021 and their projections to 2030: analysis of the global burden of disease study. Journal of Eating Disorders 2025; 13(1) doi: 10.1186/s40337-025-01289-9
|
| 5 |
Jia Hu, Kai Nie, Xiaoyan Wang. Novel ubiquitination-related biomarkers for Crohn’s disease identified by multi-omics study and experimental validation. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1687606
|
| 6 |
Likang Xu, Jinzhao Zou, Chao Sun, Gong Chen, Sujun Gao. The global academic distribution and changes in research hotspots of artificial intelligence in inflammatory bowel disease since 2000. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1600291
|
| 7 |
Yao Lu, Huijing Tang, Qianhua Fan, Ruiting Lan, Xiaoying Lin, Shuwei Zhang, Liyun Liu, Jianguo Xu. Eubacterium limosum modulates gut microbiota and produces anti-inflammatory metabolites to alleviate DSS-induced colitis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1728808
|
| 8 |
Ting Yang, Min Feng, Hui Yin, Jian-Hua Wan, Yong-Hong Liang, Xiao Zhang, Chang Peng, Tao Yang, Ming Yang, Hai-Yan Zhang. 1,2,4-trimethoxybenzene exerts multi-target effects against ulcerative colitis by inhibiting the NLRP3 inflammasome and remodeling the gut microbiota-metabolism axis. European Journal of Pharmacology 2026; 1029 doi: 10.1016/j.ejphar.2026.179059
|
| 9 |
Anas M. Almofarreh, Haytham A. Sheerah, Ahmed Arafa, Fairuz A. Algori, Ghonem R. Almutairi, Kafi A. Alenzi, Madiha M. Al-Alsehemi, Banan H. Mekwar, Osama Alzeer, Haneen N. Molla. Fruit and Vegetable Consumption and Inflammatory Bowel Disease: A Case-Control Study. Life 2024; 14(12) doi: 10.3390/life14121524
|
| 10 |
Ying Zhang, Xiaocan Jia, Yongli Yang, Na Sun, Shuyan Shi, Wei Wang. Change in the global burden of depression from 1990-2019 and its prediction for 2030. Journal of Psychiatric Research 2024; 178 doi: 10.1016/j.jpsychires.2024.07.054
|
| 11 |
Na Guo, Shen Teng, Shuyuan Chen, Jiawen Bi, Xiaolin Xu, Hongming Wang, Weiyu Teng, Weishuang Xue. Stroke attributed to kidney dysfunction from 1990 to 2021 and the prediction for 2040: an analysis of national data in China based on the Global Burden of Disease 2021 database. BMC Public Health 2025; 25(1) doi: 10.1186/s12889-025-22575-w
|
| 12 |
Keying Xu, Mengjiao Li, Ping Jiang. Symptom clusters in inflammatory bowel disease: a scoping review. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1615100
|
| 13 |
Ziyu Yuan, Liji Chen, Chong Shan Ng, Peishan Zhuang, Chongyang Huang, Jun Wang, Yao He, Beiping Zhang, Cailing Zhong, Haiyan Zhang. Analysis of global burden of inflammatory bowel disease among adolescents and young adults from 1990 to 2021 and projections to 2040. BMC Public Health 2025; 25(1) doi: 10.1186/s12889-025-24105-0
|
| 14 |
Dunja Jaksic, Sasa Vuksanovic, Aleksandar Toplicanin, Jelena Spiric-Milovancevic, Gorica Maric, Aleksandra Sokic-Milutinovic. Impact of Depression on Health-Related Quality of Life in Ulcerative Colitis Patients—Are We Doing Enough? A Single Tertiary Center Experience. Life 2025; 15(4) doi: 10.3390/life15040612
|
| 15 |
Jin Zhao, Hua Liu, Le Tong, Lingling Pu, Xiaofei Yin, Yuting Hu, Jing Yang, Yong Zhu. Global Burden of Inflammatory Bowel Disease Among Women of Reproductive Age From 1990 to 2021 and Future Projections to 2050: A Comprehensive Analysis Using Eight Machine Learning Algorithms. International Journal of Women's Health 2025; doi: 10.2147/IJWH.S551115
|
| 16 |
Jinping Chen, Zhifeng Liu, Tianyuan Yu, Yingqi Zhang, Jiayue Liu, Mengqian Lu. Global burden of inflammatory bowel disease in Group 20 countries, 1990 to 2021: A systematic analysis with projections to 2050. Medicine 2026; 105(3) doi: 10.1097/MD.0000000000047168
|
| 17 |
Yu Chen, Li Chen, Sheng Huang, Li Yang, Li Wang, Feiyun Yang, Jinxiu Huang, Xiuliang Ding. Predicting novel biomarkers for early diagnosis and dynamic severity monitoring of human ulcerative colitis. Frontiers in Genetics 2024; 15 doi: 10.3389/fgene.2024.1429482
|
| 18 |
Xuan Zhang, Lin Zhang, Juan Wang, Chung Tai Lau, Nana Wang, Xuanqi Zhang, Ping Wang, Ji Li, Fei Han, Zhaoxiang Bian. A protocol for developing, disseminating and implementing a core outcome set for clinical trials of integrative Chinese and Western medicine for ulcerative colitis. Journal of Integrative Medicine 2025; 23(6) doi: 10.1016/j.joim.2025.07.010
|
| 19 |
Ke-Jie He, Zijia Liu, Yun Kong, Guoyu Gong, Tommaso Orusa. Global Temporal Trends and Projections of DALY Burden in COPD Patients Aged ≥ 55 Years: Age–Period–Cohort Analysis and Frontiers 2021. Indoor Air 2025; 2025(1) doi: 10.1155/ina/4696858
|
| 20 |
Nachuan Chen, Shaofeng Luo, Xin Zhou, Boren Zhu, Yingyin Liu, Huaxing He, Shunli Luo, Suxia Sun. Sodium Butyrate Alleviates IBD by Modulating SIRT1-Involved Ferroptosis and Inhibition of Macrophage Ferroptosis. Nutrients 2026; 18(4) doi: 10.3390/nu18040598
|
| 21 |
Caixuan Zhang, Ying Shu, Yang Li, Fanyu Wang, Juntian Gan, Yiqian Wang, Xiaojuan Feng, Mingzhu Guo. Chinese yam (Dioscorea) polysaccharide ameliorates ulcerative colitis in mice via modulating disorders of intestinal microecology and metabolism. International Journal of Biological Macromolecules 2025; 315 doi: 10.1016/j.ijbiomac.2025.144110
|
| 22 |
Zhili Dou, Huiling Zheng, Yanyan Shi, Yuan Li, Jinzhu Jia. Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019. Autoimmunity Reviews 2024; 23(11) doi: 10.1016/j.autrev.2024.103655
|
| 23 |
Gemma Postill, James H. B. Im, Furong Tang, Eric I. Benchimol, M. Ellen Kuenzig. Unmet Healthcare Needs Among People with Inflammatory Bowel Disease: A Canadian Cross-Sectional Population-Representative Study. Digestive Diseases and Sciences 2025; 70(6) doi: 10.1007/s10620-025-09015-w
|
| 24 |
Mihaela Stoyanova, Miglena Milusheva, Vera Gledacheva, Mina Todorova, Nikoleta Kircheva, Silvia Angelova, Iliyana Stefanova, Mina Pencheva, Bela Vasileva, Kamelia Hristova-Panusheva, Natalia Krasteva, George Miloshev, Yulian Tumbarski, Milena Georgieva, Stoyanka Nikolova. Silver Nanoparticles with Mebeverine in IBS Treatment: DFT Analysis, Spasmolytic, and Anti-Inflammatory Effects. Pharmaceutics 2025; 17(5) doi: 10.3390/pharmaceutics17050561
|
| 25 |
Andréa Nicholenas, Joseph Lavelle, Gregory Mellotte, Lisa Harpur, Hugh Mulcahy, Louise McHugh. IBstressD: The effect of Acceptance and Commitment Therapy (ACT) on stress reduction in Inflammatory Bowel Disease (A pilot study). Journal of Contextual Behavioral Science 2025; 38 doi: 10.1016/j.jcbs.2025.100951
|
| 26 |
Haichen Wang, Feifei Zhou, Mengdan Shen, Ronglin Ma, Qiang Yu. Classification of Nanomaterial Drug Delivery Systems for Inflammatory Bowel Disease. International Journal of Nanomedicine 2025; doi: 10.2147/IJN.S502546
|
| 27 |
A.I. Khavkin, V.P. Novikova, A.V. Naletov, G.V. Volynets, A.A. Konstantinov, V.Yu. Bykov, T.A. Skvortsova, E.A. Yablokova, A.V. Nikitin. Current global trends in the epidemiology of inflammatory bowel diseases. Russian Journal of Evidence-Based Gastroenterology 2025; 14(3) doi: 10.17116/dokgastro202514031104
|
| 28 |
Zhongming Dai, Wen Cheng, Huan Peng, Xiaokui Qiu, Jiawen Sun, Xiaoqiang Liu, Xianjiu Sun, Jinwei Cai, Jincui Wang, Guolong Li, Yongling Lv, Shaobo Chen, Zhongying Zhong. Microbiota composition-based donor selection affects FMT efficacy in a murine colitis model. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1635244
|
| 29 |
Hailin Cheng, Lei Xiao, Tao Xu. Reduced miR-193a-3p Modulates Cell Proliferation and Apoptosis in Inflammatory Bowel Disease via Targeting ETS1. Immunological Investigations 2026; doi: 10.1080/08820139.2026.2677601
|
| 30 |
Harshad Jadhav, Arno Van Camp, Christer Tannergren, Glenn Lemmens, Joachim Brouwers, Tim Vanuytsel, Sebastian Steigert, Patrick Augustijns. Challenges in Predicting Colonic Luminal and Tissue Concentrations of Mesalamine and Acetyl Mesalamine using Physiologically Based Biopharmaceutics Modeling. International Journal of Pharmaceutics 2025; 675 doi: 10.1016/j.ijpharm.2025.125547
|
| 31 |
An Luo, Dongying Yao, Miao Wang, Liwen Jin, Zhihua Ran. Global and Chinese Burden of Inflammatory Bowel Disease From 1990 to 2021: A Systematic Analysis and Prediction of Disease Burden. JGH Open 2025; 9(5) doi: 10.1002/jgh3.70160
|
| 32 |
Jiayan Hu, Wenting Wang, Muyuan Wang, Chunye Wu, Yao Jiao, Yitong Li, Wenji Zhang, Chengtao Liang, Zhengdao Lin, Yitong Yu, Junxiang Li, Tangyou Mao. Immunological pathogenesis of inflammatory bowel disease: focus on tissue resident memory T cells. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1591584
|
| 33 |
Yanan Zhang, Yuxin Wang, Zhiyuan Zhang, Xuanrui Liu, Xinyi Kang, Wentao Yang, Xin Cao, Yanlong Jiang, Jianzhong Wang, Yan Zeng, Chunwei Shi, Haibin Huang, Chunfeng Wang, Guilian Yang, Jingwei Zhang, Nan Wang. Autophagy induced by Trichinella spiralis infection alleviate TNBS-induced colitis in mice through inhibiting the NLRP3 inflammasome. Microbial Pathogenesis 2026; 216 doi: 10.1016/j.micpath.2026.108526
|
| 34 |
Jiahao Du, Yunyun Sun, Dong Yu, Shengwei Lu, Simin Yu, Mei Wang, Guoqing Zhou, Songxin Xu, Lei Zhang, Yefei Zhu, Longxiang Zhou. Oral liposomal co-delivery of ultrasmall ceria and 5-aminosalicylic acid alleviates DSS colitis via ROS scavenging and microbiome remodeling. Journal of Materials Chemistry B 2026; 14(16) doi: 10.1039/D6TB00173D
|
| 35 |
Anas M. Almofarreh, Haytham A. Sheerah, Ahmed Arafa, Ahmed S. Al Mubarak, Aidrous M. Ali, Nasser M. Al-Otaibi, Mohammed A. Alzahrani, Atif R. Aljubayl, Mohammad A. Aleid, Suliman S. Alhamed. Dairy Consumption and Inflammatory Bowel Disease among Arab Adults: A Case–Control Study and Meta-Analysis. Nutrients 2024; 16(16) doi: 10.3390/nu16162747
|
| 36 |
Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Hilde Lapeere, Tom Hillary, An Van Laethem, Kurt de Vlam, Patrick Verschueren, Triana Lobaton, Elizaveta Padalko, Séverine Vermeire. Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study). Vaccines 2024; 12(10) doi: 10.3390/vaccines12101157
|
| 37 |
Danielle Nobre Lopes, Noêmia Pereira de Oliveira, Letícia Côgo Marques, Karla Cristina de Campos Augusto, Júlia Severino Peres Vieira, Isabelle dos Santos Xavier Dias, Bernardo Acácio Santini Pereira, Ana Luiza Miguez, Márcia Henriques Magalhães, Anna Karoline Fausto da Silva, Karin Soares Cunha, Rafaela Elvira Rozza-de-Menezes. Oral and intestinal histopathological alterations in inflammatory bowel disease: correlation with clinical activity and psychosocial factors–pilot study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2026; 141(2) doi: 10.1016/j.oooo.2025.08.019
|
| 38 |
Jessica Sosio, Mark Zemanek, Lindsey Anne Russell. Approach to Malnutrition and Oral Nutrition Therapy in Adults with IBD: What to Consider. Nutrients 2026; 18(2) doi: 10.3390/nu18020204
|
| 39 |
Veruscka Leso, Anna Testa, Daniela Pacella, Maria Carmela Macrini, Guido Daniele Villani, Paola Gervetti, Giuseppe Barbato, Antonio Rispo, Fabiana Castiglione, Ivo Iavicoli. The Impact of Inflammatory Bowel Diseases on Patients' Quality of Life and Work Functionality. Journal of Occupational & Environmental Medicine 2024; 66(11) doi: 10.1097/JOM.0000000000003213
|
| 40 |
Global, regional, and national burden of inflammatory bowel disease in persons aged 60–89 years from 1992 to 2021. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04042-3
|
| 41 |
Melanie S. Matos, María Ángeles Ávila-Gálvez, Antonio González-Sarrías, Nuno-Valério Silva, Carolina Lage Crespo, António Jacinto, Ana Teresa Serra, Ana A. Matias, Cláudia Nunes dos Santos. Unveiling the anti-inflammatory potential of 11β,13-dihydrolactucin for application in inflammatory bowel disease management. Food & Function 2024; 15(18) doi: 10.1039/D4FO01446D
|
| 42 |
Zheng Zhang, Xiao-Long Tang, Rui Ma, Liang Hao, Bo-Wen Jiang, Zhao-Nan Zhang, Yan-Jing Ni, Xin Dong, Hai-Peng Zou, Wen-Yu Luan, Zhen-Xi Xu, Wen-Jian Hu, Yu-Hui Shang, Mao-Yin Shan, Shu-Ping Zhang, Li-Na Wang, Si-Xiang Lin, Yan-Dong Miao. Global, regional, and national burdens of colorectal cancer and inflammatory bowel disease, 1990–2021 and projections to 2050: a cross-sectional study. International Journal of Surgery 2026; 112(3) doi: 10.1097/JS9.0000000000004428
|